Deep-brain stimulation for Parkinson's disease: current perspectives on patient selection with an emphasis on neuropsychology

References

• Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2006;355(9):896–908.
   PubMed Web of Science ®Google Scholar
• Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 2013;12(1):37–44.
   PubMed Web of Science ®Google Scholar
• Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11(2):140–149.
   PubMed Web of Science ®Google Scholar
• Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63–73.
   PubMed Web of Science ®Google Scholar
• Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9(6):581–591.
   PubMed Web of Science ®Google Scholar
• Charles D, Konrad PE, Davis TL, Neimat JS, Hacker ML, Finder SG. Deep brain stimulation in early stage Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(3):347–348.
   PubMed Web of Science ®Google Scholar
• Schuepbach WM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368(7):610–622.
   PubMed Web of Science ®Google Scholar
• Fundament T, Eldridge PR, Green AL, et al. Deep brain stimulation for Parkinson’s disease with early motor complications: a UK cost-effectiveness analysis. PLoS One. 2016;11(7):e0159340.
   PubMed Web of Science ®Google Scholar
• Benabid AL, Pollak P, Hoffmann D, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet. 1991;337(8738):403–406.
   PubMed Web of Science ®Google Scholar
• Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol. 1997;42(3):292–299.
   PubMed Web of Science ®Google Scholar
• Pollak P, Benabid AL, Gross C, et al. Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev Neurol. 1993;149(3):175–176.
   PubMedGoogle Scholar
• Lozano CS, Tam J, Lozano AM. The changing landscape of surgery for Parkinson’s disease. Mov Disord. 2018;33(1):36–47.
   PubMed Web of Science ®Google Scholar
• Williams NR, Foote KD, Okun MS. STN vs. GPi deep brain stimulation: translating the rematch into clinical practice. Mov Disord Clin Pract. 2014;1(1):24–35.
   PubMedGoogle Scholar
• Ramirez-Zamora A, Ostrem JL. Globus pallidus interna or subthalamic nucleus deep brain stimulation for Parkinson disease. JAMA Neurol. 2018;75(3):367–372.
   PubMed Web of Science ®Google Scholar
• Rughani A, Schwalb JM, Sidiropoulos C, et al. Congress of Neurological Surgeons Systematic review and evidence-based guideline on subthalamic nucleus and globus pallidus internus deep brain stimulation for the treatment of patients with Parkinson’s disease: executive summary. Neurosurgery. 2018;82(6):753–756.
   PubMed Web of Science ®Google Scholar
• Maier F, Lewis CJ, Horstkoetter N, et al. Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson’s disease: a mixed-method approach. J Neurol Neurosurg Psychiatry. 2013;84(11):1273–1281.
   PubMed Web of Science ®Google Scholar
• Hogg E, Wertheimer J, Graner S, Tagliati M. Deep brain stimulation and nonmotor symptoms. Int Rev Neurobiol. 2017;134:1045–1089.
   PubMed Web of Science ®Google Scholar
• Rose KJ, Derry PA, Mclachlan RS. Patient expectations and postoperative depression, anxiety, and psychosocial adjustment after temporal lobectomy: A prospective study. Int J Behav Med. 1995;2(1):27–40.
   PubMed Web of Science ®Google Scholar
• Wheelock I, Peterson C, Buchtel HA. Presurgery expectations, postsurgery satisfaction, and psychosocial adjustment after epilepsy surgery. Epilepsia. 1998;39(5):487–494.
   PubMed Web of Science ®Google Scholar
• Wilson SJ, Saling MM, Kincade P, Bladin PF. Patient expectations of temporal lobe surgery. Epilepsia. 1998;39(2):167–174.
   PubMed Web of Science ®Google Scholar
• dos Santos JF, du Montcel ST, Gargiulo M, et al. Tackling psychosocial maladjustment in Parkinson’s disease patients following subthalamic deep-brain stimulation: a randomised clinical trial. PLoS One. 2017;12(4): e0174512.
   PubMed Web of Science ®Google Scholar
• Lanier-Bohan EM, Heath SL. Patient and caregiver perspectives of preoperative teaching for deep brain stimulation surgery. J Neurosci Nurs. 2016;48(5):247–255.
   PubMed Web of Science ®Google Scholar
• Coleman RR, Kotagal V, Patil PG, Chou KL. Validity and efficacy of screening algorithms for assessing deep brain stimulation candidacy in Parkinson’s disease. Mov Disord Clin Pract. 2014;1(4):342–347.
   PubMedGoogle Scholar
• Anderson DG, van Coller R, Carr J. South African guideline on deep brain stimulation for Parkinson’s disease. S Afr Med J. 2017;107(10):1027–1032.
   PubMedGoogle Scholar
• Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011;68(2):165.
   PubMed Web of Science ®Google Scholar
• Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord. 2006;21(S14):S171–S196.
   PubMedGoogle Scholar
• Panisset M, Picillo M, Jodoin N, et al. Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada. Can J Neurol Sci. 2017;44(2):132–138.
   PubMed Web of Science ®Google Scholar
• Moro E, Allert N, Eleopra R, et al. A decision tool to support appropriate referral for deep brain stimulation in Parkinson’s disease. J Neurol. 2009;256(1):83–88.
   PubMed Web of Science ®Google Scholar
• Okun MS, Fernandez HH, Pedraza O, et al. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology. 2004;63(1):161–163.
   PubMed Web of Science ®Google Scholar
• Wächter T, Mínguez-Castellanos A, Valldeoriola F, Herzog J, Stoevelaar H. A tool to improve pre-selection for deep brain stimulation in patients with Parkinson’s disease. J Neurol. 2011;258(4):641–646.
   PubMed Web of Science ®Google Scholar
• Okun MS, Fernandez HH, Rodriguez RL, Foote KD. Identifying candidates for deep brain stimulation in Parkinson’s disease: the role of the primary care physician. Geriatrics. 2007;62(5):18–24.
   PubMed Web of Science ®Google Scholar
• Tröster AI. Some clinically useful information that neuropsychology provides patients, carepartners, neurologists, and neurosurgeons about deep brain stimulation for Parkinson’s disease. Arch Clin Neuropsychol. 2017;32(7):810–828.
   PubMed Web of Science ®Google Scholar
• Abboud H, Mehanna R, Machado A. Comprehensive, multidisciplinary deep brain stimulation screening for Parkinson patients: no room for “short cuts”. Mov Disord Clin Pract. 2014;1(4):336–341.
   PubMedGoogle Scholar
• Lopiano L, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes. J Neurol Sci. 2002;195(2):167–170.
   PubMed Web of Science ®Google Scholar
• Coleman RR, Kotagal V, Patil PG, Chou KL. Validity and efficacy of screening algorithms for assessing deep brain stimulation candidacy in Parkinson’s disease. Mov Disord Clin Pract. 2014;1(4):342–347.
   PubMedGoogle Scholar
• Mirza S, Yazdani U, Dewey R, et al. Comparison of globus pallidus interna and subthalamic nucleus in deep brain stimulation for Parkinson disease: an institutional experience and review. Parkinsons Dis. 2017;2017(3):3410820.
   PubMedGoogle Scholar
• Barry MJ, Edgman-Levitan S. Shared decision making: the pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–781.
   PubMed Web of Science ®Google Scholar
• Hamberg K, Hariz GM. The decision-making process leading to deep brain stimulation in men and women with Parkinson’s disease: an interview study. BMC Neurol. 2014;14:89.
   PubMed Web of Science ®Google Scholar
• Burandt CA, Lebowitz BK, Tröster AI, O’Connor MG. The role of neuropsychology in the evaluation of surgical candidates for deep brain stimulation in Parkinson’s disease: a survey study. Clin Neuropsychol. 2008;22(3):390.
   Web of Science ®Google Scholar
• Marras C, Tröster AI, Kulisevsky J, Stebbins GT. The tools of the trade: a state of the art “how to assess cognition” in the patient with Parkinson’s disease. Mov Disord. 2014;29(5):584–596.
   PubMed Web of Science ®Google Scholar
• Hariz MI, Johansson F, Shamsgovara P, Johansson E, Hariz GM, Fagerlund M. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency – a case study. Mov Disord. 2000;15(1):136–139.
   PubMed Web of Science ®Google Scholar
• Massano J, Garrett C. Deep brain stimulation and cognitive decline in Parkinson’s disease: a clinical review. Front Neurol. 2012;3:66.
   PubMedGoogle Scholar
• Kubu CS, Ford PJ. Clinical ethics in the context of deep brain stimulation for movement disorders. Arch Clin Neuropsychol. 2017;32(7):829–839.
   PubMed Web of Science ®Google Scholar
• Freund HJ, Kuhn J, Lenartz D, et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol. 2009;66(6):781–785.
   PubMed Web of Science ®Google Scholar
• Gratwicke J, Zrinzo L, Kahan J, et al. Bilateral deep brain stimulation of the nucleus basalis of Meynert for Parkinson disease dementia: a randomized clinical trial. JAMA Neurol. 2018;75(2):169–178.
   PubMed Web of Science ®Google Scholar
• Castrioto A, Lhommée E, Moro E, Krack P. Mood and behavioural effects of subthalamic stimulation in Parkinson’s disease. Lancet Neurol. 2014;13(3):287–305.
   PubMed Web of Science ®Google Scholar
• Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol. 2010;6(9):487–498.
   PubMed Web of Science ®Google Scholar
• Witt K, Daniels C, Volkmann J. Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18 Suppl 1:S168–S170.
   Google Scholar
• Erasmi R, Deuschl G, Witt K. Tiefe Hirnstimulation bei Morbus Parkinson: wann und fuer wen? [Deep brain stimulation for Parkinson’s disease: timing and patient selection]. Nervenarzt. 2014;85(2):137–146. German.
   PubMed Web of Science ®Google Scholar
• Munhoz RP, Picillo M, Fox SH, et al. Eligibility criteria for deep brain stimulation in Parkinson’s disease, tremor, and dystonia. Can J Neurol Sci. 2016;43(4):462–471.
   PubMed Web of Science ®Google Scholar
• Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain. 2008;131(10):2720–2728.
   PubMedGoogle Scholar
• Smeding HM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2011;82(7):754–760.
   PubMed Web of Science ®Google Scholar
• Odekerken VJ, Boel JA, Geurtsen GJ, et al. Neuropsychological outcome after deep brain stimulation for Parkinson disease. Neurology. 2015;84(13):1355–1361.
   PubMed Web of Science ®Google Scholar
• Tröster AI, Jankovic J, Tagliati M, Peichel D, Okun MS. Neuropsychological outcomes from constant current deep brain stimulation for Parkinson’s disease. Mov Disord. 2017;32(3):433–440.
   PubMed Web of Science ®Google Scholar
• Combs HL, Folley BS, Berry DT, et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson’s disease: a meta-analysis. Neuropsychol Rev. 2015;25(4):439–454.
   PubMed Web of Science ®Google Scholar
• Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society task force guidelines. Mov Disord. 2012;27(3):349–356.
   PubMed Web of Science ®Google Scholar
• Yágüez L, Costello A, Moriarty J, et al. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease. J Clin Neurosci. 2014;21(3):445–450.
   PubMed Web of Science ®Google Scholar
• Tröster A, Woods S, Morgan E. Assessing cognitive change in Parkinson’s disease: development of practice effect-corrected reliable change indices. Arch Clin Neuropsychol. 2007;22(6):711–718.
   PubMed Web of Science ®Google Scholar
• Pedersen KF, Larsen JP, Tysnes OB, Alves G. Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology. 2017;88(8):767–774.
   PubMed Web of Science ®Google Scholar
• Abboud H, Floden D, Thompson NR, et al. Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(3):249–253.
   PubMed Web of Science ®Google Scholar
• Kim H-J, Jeon BS, Paek SH, et al. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease. J Neurol. 2014;261(6):1090–1096.
   PubMed Web of Science ®Google Scholar
• Hoogland J, Boel JA, de Bie RM, et al. Mild cognitive impairment as a risk factor for Parkinson’s disease dementia. Mov Disord. 2017;32(7):1056–1065.
   PubMed Web of Science ®Google Scholar
• Merola A, Rizzi L, Artusi CA, et al. Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. J Neurol. 2014;261(9):1745–1751.
   PubMed Web of Science ®Google Scholar
• Maier F, Lewis CJ, Horstkoetter N, et al. Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson’s disease one year after surgery. Parkinsonism Relat Disord. 2016;24:41–47.
   PubMed Web of Science ®Google Scholar
• Schüpbach M, Gargiulo M, Welter ML, et al. Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology. 2006;66(12):1811–1816.
   PubMed Web of Science ®Google Scholar
• Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson’s disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry. 2002;72(6):701–707.
   PubMed Web of Science ®Google Scholar
• Lewis CJ, Maier F, Horstkötter N, et al. The impact of subthalamic deep brain stimulation on caregivers of Parkinson’s disease patients: an exploratory study. J Neurol. 2015;262(2):337–345.
   PubMed Web of Science ®Google Scholar
• Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Neurology. 1998;51(3):850–855.
   PubMed Web of Science ®Google Scholar
• Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998;339(16):1105–1111.
   PubMed Web of Science ®Google Scholar
• Dafsari HS, Reker P, Stalinski L, et al. Quality of life outcome after subthalamic stimulation in Parkinson’s disease depends on age. Mov Disord. 2018;33(1):99–107.
   PubMed Web of Science ®Google Scholar
• Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord. 2007;22(15):2149–2155.
   PubMed Web of Science ®Google Scholar
• Meissner WG, Laurencin C, Tranchant C, et al. Outcome of deep brain stimulation in slowly progressive multiple system atrophy: a clinico-pathological series and review of the literature. Parkinsonism Relat Disord. 2016;24:69–75.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Violante M, Cervantes-Arriaga A, Fahn S, Tolosa E. Two-hundred years later: is Parkinson’s disease a single defined entity? Rev Invest Clin. 2017;69(6):308–313.
   PubMedGoogle Scholar
• Katz M, Luciano MS, Carlson K, et al. Differential effects of deep brain stimulation target on motor subtypes in Parkinson’s disease. Ann Neurol. 2015;77(4):710–719.
   PubMed Web of Science ®Google Scholar
• Thevathasan W, Debu B, Aziz T, et al. Pedunculopontine nucleus deep brain stimulation in Parkinson’s disease: a clinical review. Mov Disord. 2018;33(1):10–20.
   PubMed Web of Science ®Google Scholar
• Mazzone P, Scarnati E, Garcia-Rill E. The pedunculopontine nucleus: clinical experience, basic questions and future directions. J Neural Transm (Vienna). 2011;118(10):1391–1396.
   PubMed Web of Science ®Google Scholar
• Morita H, Hass CJ, Moro E, Sudhyadhom A, Kumar R, Okun MS. Pedunculopontine nucleus stimulation: where are we now and what needs to be done to move the field forward? Front Neurol. 2014; 5:243.
   PubMed Web of Science ®Google Scholar
• Hamani C, Lozano AM, Mazzone PAM, et al. Pedunculopontine nucleus region deep brain stimulation in Parkinson disease: surgical techniques, side effects, and postoperative imaging. Stereotact Funct Neurosurg. 2016;94(5):307–319.
   PubMed Web of Science ®Google Scholar
• Fischer J, Schwiecker K, Bittner V, et al. Modulation of attentional processing by deep brain stimulation of the pedunculopontine nucleus region in patients with parkinsonian disorders. Neuropsychology. 2015;29(4):632–637.
   PubMed Web of Science ®Google Scholar
• Mesnage V, Houeto JL, Welter ML, et al. Parkinson’s disease: neurosurgery at an earlier stage? J Neurol Neurosurg Psychiatry. 2002;73(6):778–779.
   PubMed Web of Science ®Google Scholar
• Tramontana MG, Molinari AL, Konrad PE, et al. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson’s disease in a randomized clinical trial. J Parkinsons Dis. 2015;5(1):151–163.
   PubMedGoogle Scholar
• Mestre TA, Espay AJ, Marras C, Eckman MH, Pollak P, Lang AE. Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson’s disease – the EARLYSTIM trial: early is not always better. Mov Disord. 2014;29(14):1751–1756.
   PubMed Web of Science ®Google Scholar
• Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362(22):2077–2091.
   PubMed Web of Science ®Google Scholar
• Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 2012;79(1):55–65.
   PubMed Web of Science ®Google Scholar
• Southwell DG, Rutkowski MJ, San Luciano M, et al. Before and after the veterans affairs cooperative program 468 study: deep brain stimulator target selection for treatment of Parkinson’s disease. Parkinsonism Relat Disord. 2018;48:40–44.
   PubMed Web of Science ®Google Scholar
• Boel JA, Odekerken VJ, Geurtsen GJ, et al. Psychiatric and social outcome after deep brain stimulation for advanced Parkinson’s disease. Mov Disord. 2016;31(3):409–413.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li W, Tan C, et al. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease. J Neurosurg. 2014;121(3):709–718.
   PubMed Web of Science ®Google Scholar
• Evidente VG, Premkumar AP, Adler CH, Caviness JN, Driver-Dunckley E, Lyons MK. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson’s disease. Acta Neurol Scand. 2011;124(3):211–214.
   PubMed Web of Science ®Google Scholar
• Rothlind JC, Cockshott RW, Starr PA, Marks WJ. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson’s disease. J Int Neuropsychol Soc. 2007;13(01):68–79.
   PubMedGoogle Scholar
• Hershey T, Wu J, Weaver PM, et al. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol. 2008;210(2):402–408.
   PubMed Web of Science ®Google Scholar
• Taba HA, Wu SS, Foote KD, et al. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg. 2010;113(6):1224–1229.
   PubMed Web of Science ®Google Scholar
• Larson PS. Deep brain stimulation for movement disorders. Neurotherapeutics. 2014;11(3):465–474.
   PubMed Web of Science ®Google Scholar
• Brodsky MA, Anderson S, Murchison C, et al. Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease. Neurology. 2017;89(19):1944–1950.
   PubMed Web of Science ®Google Scholar
• Mirzadeh Z, Chapple K, Lambert M, et al. Parkinson’s disease outcomes after intraoperative CT-guided “asleep” deep brain stimulation in the globus pallidus internus. J Neurosurg. 2016;124(4):902–907.
   PubMed Web of Science ®Google Scholar
• Sidiropoulos C, Rammo R, Merker B, et al. Intraoperative MRI for deep brain stimulation lead placement in Parkinson’s disease: 1-year motor and neuropsychological outcomes. J Neurol. 2016;263(6):1226–1231.
   PubMed Web of Science ®Google Scholar
• Dembek TA, Reker P, Visser-Vandewalle V, et al. Directional DBS increases side-effect thresholds: a prospective, double-blind trial. Mov Disorders. 2017;32(10):1380–1388.
   PubMed Web of Science ®Google Scholar
• ten Brinke TR, Odekerken VJ, Dijk JM, van den Munckhof P, Schuurman PR, de Bie RM. Directional deep brain stimulation: first experiences in centers across the globe. Brain Stimul. 2018; 11(4):949–950.
   PubMed Web of Science ®Google Scholar
• Witt K, Daniels C, Krack P, et al. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson’s disease. J Neurol Sci. 2011;310(1–2):261–266.
   PubMed Web of Science ®Google Scholar
• Hrabovsky D, Balaz M, Rab M, et al. Factors responsible for early postoperative mental alterations after bilateral implantation of subthalamic electrodes. Br J Neurosurg. 2017;31(2):212–216.
   PubMed Web of Science ®Google Scholar
• Blume J, Lange M, Rothenfusser E, et al. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson’s disease. Clin Neurol Neurosurg. 2017;159:87–92.
   PubMed Web of Science ®Google Scholar
• Fukaya C, Watanabe M, Kobayashi K, Oshima H, Yoshino A, Yamamoto T. Predictive factors for long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease. Neurol Med Chir (Tokyo). 2017;57(4):166–171.
   PubMed Web of Science ®Google Scholar
• Daniels C, Krack P, Volkmann J, et al. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson’s disease. Mov Disord. 2010;25(11):1583–1589.
   PubMed Web of Science ®Google Scholar
• Geevarghese R, Lumsden DE, Costello A, et al. Verbal memory decline following DBS for Parkinson’s disease: structural volumetric MRI relationships. PLoS One. 2016;11(8):e0160583.
   PubMed Web of Science ®Google Scholar
• Pilitsis JG, Rezai AR, Boulis NM, Henderson JM, Busch RM, Kubu CS. A preliminary study of transient confusional states following bilateral subthalamic stimulation for Parkinson’s disease. Stereotact Funct Neurosurg. 2005;83(2–3):67–70.
   PubMed Web of Science ®Google Scholar
• Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson’s disease. J Neurol. 2005;252(5):583–588.
   PubMed Web of Science ®Google Scholar
• Schoenberg MR, Mash KM, Bharucha KJ, Francel PC, Scott JG. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson’s disease. Stereotact Funct Neurosurg. 2008;86(6):337–344.
   PubMed Web of Science ®Google Scholar